Halozyme Therapeutics Inc (HALO)
43.15
-0.69
(-1.57%)
USD |
NASDAQ |
May 10, 16:00
42.00
-1.15
(-2.67%)
After-Hours: 20:00
Halozyme Therapeutics Price: 43.15 for May 10, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| May 10, 2024 | 44.08 | 44.21 | 43.12 | 43.15 | 1.005M |
| May 09, 2024 | 42.20 | 43.92 | 41.28 | 43.84 | 1.441M |
| May 08, 2024 | 41.95 | 44.78 | 41.43 | 42.01 | 2.121M |
| May 07, 2024 | 41.10 | 41.66 | 40.87 | 41.21 | 1.282M |
| May 06, 2024 | 40.36 | 40.97 | 40.18 | 40.86 | 981079.0 |
| May 03, 2024 | 40.67 | 40.74 | 39.79 | 39.91 | 902802.0 |
| May 02, 2024 | 39.56 | 40.74 | 38.88 | 39.82 | 832175.0 |
| May 01, 2024 | 38.40 | 40.00 | 38.30 | 39.30 | 1.032M |
| Apr 30, 2024 | 38.54 | 39.03 | 37.96 | 38.10 | 922527.0 |
| Apr 29, 2024 | 38.76 | 39.39 | 38.56 | 38.77 | 728580.0 |
| Apr 26, 2024 | 38.46 | 39.02 | 38.46 | 38.57 | 547134.0 |
| Apr 25, 2024 | 38.71 | 38.75 | 38.23 | 38.46 | 693350.0 |
| Apr 24, 2024 | 38.98 | 39.70 | 38.82 | 39.12 | 620516.0 |
| Apr 23, 2024 | 38.75 | 39.42 | 38.70 | 38.97 | 557948.0 |
| Apr 22, 2024 | 38.82 | 39.04 | 38.28 | 38.71 | 525232.0 |
| Apr 19, 2024 | 37.73 | 38.69 | 37.73 | 38.64 | 1.259M |
| Apr 18, 2024 | 37.95 | 38.41 | 37.73 | 37.81 | 792530.0 |
| Apr 17, 2024 | 38.69 | 38.78 | 37.98 | 38.02 | 733857.0 |
| Apr 16, 2024 | 38.35 | 38.81 | 38.08 | 38.38 | 642294.0 |
| Apr 15, 2024 | 38.89 | 39.27 | 38.48 | 38.72 | 843658.0 |
| Apr 12, 2024 | 39.00 | 39.28 | 38.53 | 38.61 | 780317.0 |
| Apr 11, 2024 | 39.49 | 39.79 | 39.16 | 39.32 | 733624.0 |
| Apr 10, 2024 | 39.25 | 39.84 | 38.90 | 39.28 | 1.882M |
| Apr 09, 2024 | 40.07 | 40.71 | 39.52 | 40.13 | 719105.0 |
| Apr 08, 2024 | 41.09 | 41.36 | 39.85 | 39.91 | 1.164M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
13.90
Minimum
Mar 18 2020
59.44
Maximum
Dec 02 2022
35.28
Average
38.36
Median
Feb 21 2024
Price Benchmarks
| Novavax Inc | 8.88 |
| Globus Medical Inc | 64.72 |
| Denali Therapeutics Inc | 18.31 |
| AIM ImmunoTech Inc | 0.40 |
| Protalix BioTherapeutics Inc | 1.10 |
Price Related Metrics
| PE Ratio | 17.83 |
| PS Ratio | 6.595 |
| PEG Ratio | 0.2104 |
| Price to Book Value | 30.89 |
| Price to Free Cash Flow | 13.44 |
| Earnings Yield | 5.61% |
| Market Cap | 5.492B |
| PEGY Ratio | 0.2104 |
| Operating PE Ratio | 15.00 |
| Normalized PE Ratio | 19.37 |